1091 related articles for article (PubMed ID: 33212126)
1. Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis.
Galanis P; Vraka I; Fragkou D; Bilali A; Kaitelidou D
J Hosp Infect; 2021 Feb; 108():120-134. PubMed ID: 33212126
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a London NHS Trust.
Grant JJ; Wilmore SMS; McCann NS; Donnelly O; Lai RWL; Kinsella MJ; Rochford HL; Patel T; Kelsey MC; Andrews JA
Infect Control Hosp Epidemiol; 2021 Feb; 42(2):212-214. PubMed ID: 32746953
[TBL] [Abstract][Full Text] [Related]
3. Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis.
Bobrovitz N; Arora RK; Cao C; Boucher E; Liu M; Donnici C; Yanes-Lane M; Whelan M; Perlman-Arrow S; Chen J; Rahim H; Ilincic N; Segal M; Duarte N; Van Wyk J; Yan T; Atmaja A; Rocco S; Joseph A; Penny L; Clifton DA; Williamson T; Yansouni CP; Evans TG; Chevrier J; Papenburg J; Cheng MP
PLoS One; 2021; 16(6):e0252617. PubMed ID: 34161316
[TBL] [Abstract][Full Text] [Related]
4. The seroprevalence of SARS-CoV-2 antibodies among health care workers before the era of vaccination: a systematic review and meta-analysis.
Kayı İ; Madran B; Keske Ş; Karanfil Ö; Arribas JR; Psheniсhnaya N; Petrosillo N; Gönen M; Ergönül Ö
Clin Microbiol Infect; 2021 Sep; 27(9):1242-1249. PubMed ID: 34116205
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of SARS-CoV-2 IgG antibodies and risk factors in health care workers at an academic medical center in Boston, Massachusetts.
Kataria Y; Cole M; Duffy E; de la Cena K; Schechter-Perkins EM; Bouton TC; Werler MM; Pierre C; Ragan EJ; Weber SE; Jacobson KR; Andry C
Sci Rep; 2021 May; 11(1):9694. PubMed ID: 33958668
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal assessment of SARS-CoV-2 IgG seroconversionamong front-line healthcare workers during the first wave of the Covid-19 pandemic at a tertiary-care hospital in Chile.
Iruretagoyena M; Vial MR; Spencer-Sandino M; Gaete P; Peters A; Delgado I; Perez I; Calderon C; Porte L; Legarraga P; Anderson A; Aguilera X; Vial P; Weitzel T; Munita JM
BMC Infect Dis; 2021 May; 21(1):478. PubMed ID: 34039287
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of SARS-CoV-2 antibodies, associated epidemiological factors and antibody kinetics among healthcare workers in Connecticut.
Papasavas P; Olugbile S; Wu U; Robinson K; Roberts AL; O'Sullivan DM; McLaughlin T; Mather JF; Steinberg AC; Orlando R; Kumar A
J Hosp Infect; 2021 Aug; 114():117-125. PubMed ID: 33930487
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Anti-SARS-CoV-2 Specific Antibodies in Health-Care Workers Compared to General Population during an Early Phase of the Pandemic, Tehran-Iran.
Mortezagholi S; Rostamzadeh D; Alinejad M; Younesi V; Tabarsi P; Shabani M
Iran J Immunol; 2021 Mar; 18(1):82-92. PubMed ID: 33787517
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of antibodies to SARS-CoV-2 in Irish hospital healthcare workers.
Allen N; Riain UN; Conlon N; Ferenczi A; Carrion Martin AI; Domegan L; Walsh C; Doherty L; O'Farrelly C; Higgins E; Kerr C; McGrath J; ; Fleming C; Bergin C
Epidemiol Infect; 2021 Apr; 149():e157. PubMed ID: 33902786
[TBL] [Abstract][Full Text] [Related]
10. Cross-sectional prevalence of SARS-CoV-2 antibodies in healthcare workers in paediatric facilities in eight countries.
Goldblatt D; Johnson M; Falup-Pecurariu O; Ivaskeviciene I; Spoulou V; Tamm E; Wagner M; Zar HJ; Bleotu L; Ivaskevicius R; Papadatou I; Jõgi P; Lischka J; Franckling-Smith Z; Isarova D; Grandjean L; Zavadska D
J Hosp Infect; 2021 Apr; 110():60-66. PubMed ID: 33422589
[TBL] [Abstract][Full Text] [Related]
11. Population-based seroprevalence surveys of anti-SARS-CoV-2 antibody: An up-to-date review.
Lai CC; Wang JH; Hsueh PR
Int J Infect Dis; 2020 Dec; 101():314-322. PubMed ID: 33045429
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of SARS-CoV-2 Binding and Neutralizing Antibodies in Healthcare Workers during the Epidemic Peak in Referral Hospitals and Quarantine Sites: Saudi Arabia.
Alhabbab RY; Alsaieedi A; Algaissi A; Almahboub S; Al-Raddadi RM; Shabouni OI; Alhabbab R; Alfaraj AA; Alamri SS; Aljehani ND; Abdulal RH; Alfaleh MA; Abujamel TS; Alkayyal AA; Mahmoud AB; Abuzenadah AM; Hashem AM
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372618
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of SARS-CoV-2 antibody among healthcare workers in a university hospital in Mallorca, Spain, during the first wave of the COVID-19 pandemic.
Rodriguez A; Arrizabalaga-Asenjo M; Fernandez-Baca V; Lainez MP; Al Nakeeb Z; Garcia JD; Payeras A
Int J Infect Dis; 2021 Apr; 105():482-486. PubMed ID: 33647507
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays.
Allen N; Brady M; Carrion Martin AI; Domegan L; Walsh C; Houlihan E; Kerr C; Doherty L; King J; Doheny M; Griffin D; Molloy M; Dunne J; Crowley V; Holmes P; Keogh E; Naughton S; Kelly M; O'Rourke F; Lynagh Y; Crowley B; de Gascun C; Holder P; Bergin C; Fleming C; Ni Riain U; Conlon N;
Microbiol Spectr; 2021 Oct; 9(2):e0039121. PubMed ID: 34585976
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence and risk factors of COVID-19 in healthcare workers from 11 African countries: a scoping review and appraisal of existing evidence.
Müller SA; Wood RR; Hanefeld J; El-Bcheraoui C
Health Policy Plan; 2022 Apr; 37(4):505-513. PubMed ID: 34726740
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of personal protective equipment in preventing severe acute respiratory syndrome coronavirus 2 infection among healthcare workers.
Suzuki T; Hayakawa K; Ainai A; Iwata-Yoshikawa N; Sano K; Nagata N; Suzuki T; Wakimoto Y; Akiyama Y; Miyazato Y; Nakamura K; Ide S; Nomoto H; Nakamoto T; Ota M; Moriyama Y; Sugiki Y; Saito S; Morioka S; Ishikane M; Kinoshita N; Kutsuna S; Ohmagari N
J Infect Chemother; 2021 Jan; 27(1):120-122. PubMed ID: 32988731
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare workers with differing levels of coronavirus disease 2019 (COVID-19) patient exposure.
Hunter BR; Dbeibo L; Weaver CS; Beeler C; Saysana M; Zimmerman MK; Weaver L
Infect Control Hosp Epidemiol; 2020 Dec; 41(12):1441-1442. PubMed ID: 32741406
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of SARS-CoV-2 IgG antibodies among health care workers prior to vaccine administration in Europe, the USA and East Asia: A systematic review and meta-analysis.
Hossain A; Nasrullah SM; Tasnim Z; Hasan MK; Hasan MM
EClinicalMedicine; 2021 Mar; 33():100770. PubMed ID: 33718853
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive infection control measures prevent hospital-acquired severe acute respiratory syndrome coronavirus 2 infection: A single-center prospective cohort study and seroprevalence survey.
Hori H; Fukuchi T; Sanui M; Moriya T; Sugawara H
PLoS One; 2021; 16(10):e0257513. PubMed ID: 34634076
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study.
Meylan S; Dafni U; Lamoth F; Tsourti Z; Lobritz MA; Regina J; Bressin P; Senn L; Grandbastien B; Andre C; Fenwick C; D'Acremont V; Croxatto A; Guilleret I; Greub G; Manuel O; Calandra T; Pantaleo G; Lazor-Blanchet C;
BMJ Open; 2021 Jul; 11(7):e049232. PubMed ID: 34226231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
